SAR442970
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SAR442970, covering 2026-01-29 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis [Phase 2]